SD in Subjects With T2DM.

Trial Profile

SD in Subjects With T2DM.

Phase of Trial: Phase I

Latest Information Update: 04 Jul 2014

At a glance

  • Drugs JNJ 38431055 (Primary) ; Sitagliptin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 01 Aug 2012 Results published in the Diabetes, Obesity and Metabolism.
    • 09 Dec 2009 Actual patient number (25) added as reported by
    • 29 Aug 2009 Status changed from active, no longer recruiting to completed as reported by
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top